Journal ArticleDOI
Evaluation of data quality in the cancer registry: Principles and methods Part II. Completeness.
D. Max Parkin,Freddie Bray +1 more
Reads0
Chats0
TLDR
This second instalment of a two-part review of data quality methods at the cancer registry focuses on the principles and techniques available for estimating completeness, separating methods into those that are semi-quantitative -- in that they give an indication of the degree of completeness relative to other registries or over time, and more quantitative techniques -- those that provide a numerical evaluation.About:
This article is published in European Journal of Cancer.The article was published on 2009-03-01. It has received 417 citations till now. The article focuses on the topics: Cancer registry & Population.read more
Citations
More filters
Journal ArticleDOI
Évaluation de l’exhaustivité et de la qualité des données du cancer de la thyroïde dans un registre du cancer dans la population algérienne
Houda Boukheris,Lila Brakni,Reda Fihri Boubezari,Arslan Bettayeb,N. Bachir Bouaidjra,A. Bensetti Houari,Farouk Mohamed Brahim,A. Simerabet,Zineb Achour,Sara Attar,H. Saim,N. Berber +11 more
TL;DR: In this paper , the authors assessed thyroid cancer incidence and trends in Oran for the period 1996-2013 with the historical data method using the multisource approach and the independent case ascertainment method.
Patent
Inhibiteurs d'enzymes phosphohydrolase d'acide phosphatidique (pap) comprenant du d-propranolol et analogues, seuls ou combinés à de la désipramine, pour traiter des cancers qui dépendent du récepteur du facteur de croissance épidermique (egfr), ses variants oncogènes et autres membres de la famille des récepteurs tyrosine-kinases erbb/her
TL;DR: The presente invention concerne l'utilisation de composes et combinaisons de ceux-ci qui inhibent l'enzyme phosphohydrolase d'acide phosphatidique (PAP) pour la formulation de medicaments utilises pour traiter le cancer as discussed by the authors.
Journal ArticleDOI
Use of routinely collected health data in randomised clinical trials: comparison of trial-specific death data in the BOSS trial with NHS Digital data.
Sharon Love,Anna Kilanowski,Victoria Yorke-Edwards,Oliver Old,Hugh Barr,Clive Stokes,Catherine Kendall,Matthew R. Sydes +7 more
TL;DR: It is suggested that this assessment of registry data is done for more phase III RCTs and for more registry data to get a more complete picture of when RCHD would be useful in phaseIII RCT.
Journal ArticleDOI
The oncoprotein HBXIP – its functions and roles in oncogenesis
Małgorzata Grudzińska,Karolina Lomperta,Katarzyna Jakubowska,P. Samocik,K. Jarząbek,Luiza Kanczuga-Koda,A. Wincewicz,Mariusz Koda +7 more
TL;DR: According to recent studies, HBXIP can be used as a prognostic biomarker in many tumors, including cervical cancer, ovarian cancer, and esophageal squamous cell carcinoma thanks to the high expression of this protein noted exclusively in these tumor tissues.
Journal ArticleDOI
Epidemiological aspects in cancer registration systems in Russia and around the world
A.S. Slinin,O.I. Bydanov +1 more
TL;DR: In this article , the authors overviewed epidemiological aspects in cancer registration systems in Russia and around the world and used the methods of cancer registration in children applied in developed countries to improve childhood cancer registration.
References
More filters
Book
Cancer Incidence in Five Continents
Freddie Bray,J. Ferlay,Mathieu Laversanne,David H. Brewster,C. Gombe Mbalawa,B. Kohler,Marion Piñeros,Eva Steliarova-Foucher,Rajaraman Swaminathan,Sebastien Antoni,Isabelle Soerjomataram,David Forman +11 more
TL;DR: The aim of this study was to establish a database of histological groups and to provide a level of consistency and quality of data that could be applied in the design of future registries.
SEER Cancer Statistics Review, 1975-2003, National Cancer Institute. Bethesda, MD,
Ries Lag,D. Harkins,Krapcho M,Angela B. Mariotto,Miller Ba,Eric J. Feuer,Limin X. Clegg,M. P. Eisner,Horner Mj,Nadia Howlader,Matthew J. Hayat,Benjamin F. Hankey,Brenda K. Edwards,Seer web site +13 more
Journal ArticleDOI
Data quality at the Cancer Registry of Norway: An overview of comparability, completeness, validity and timeliness
Inger Kristin Larsen,Milada Cvancarova Småstuen,Tom Børge Johannesen,Frøydis Langmark,Donald Maxwell Parkin,Freddie Bray,Bjørn Møller +6 more
TL;DR: The routines in place at the CRN yields comparable data that can be considered reasonably accurate, close-to-complete and timely, thereby justifying the policy of the reporting of annual incidence one year after the year of diagnosis.
Journal ArticleDOI
Capture-Recapture Methods in Epidemiology: Methods and Limitations
Ernest B. Hook,Ronald R. Regal +1 more
Journal ArticleDOI
Cancer incidence in five continents, vol. VI
TL;DR: Africa, Central and South, and Caribbean Argentina, Chaco 11 0.5 0.4 0.17 0.02 Chile, Concepcion 6 0.2 0.06 0.03 Brazil, Aracaju 4 0.3 0.05 0.01 0.04 0 − *Brazil, Goiânia 17 0.6 0.24 0.08 0.07 0.09 *South Africa, Eastern Cape 5 0.1 0.11 0